Indication
Alcoholic Liver Disease
5 clinical trials
6 products
Clinical trial
Alterations of the Brain-Gut-Microbiome Axis Modulates Sex Differences in Outcomes of Alcohol-Related Liver DiseaseStatus: Recruiting, Estimated PCD: 2024-09-01
Product
VSL #3Clinical trial
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Study of Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy DrinkersStatus: Recruiting, Estimated PCD: 2024-12-31
Product
AlirocumabClinical trial
Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.Status: Not yet recruiting, Estimated PCD: 2025-03-31
Product
NaltrexonProduct
BaclofenClinical trial
A Phase I Clinical Trial to Determine the Safety and Tolerability of Anti-IL23 Monoclonal Antibody, for the Treatment of Patients With Alcohol Associated Liver DiseaseStatus: Recruiting, Estimated PCD: 2024-03-31
Product
GuselkumabClinical trial
Study of the Evolution of the Intestinal Microbiome (Taxonomic and Functional Composition) During Alcoholic Liver DiseaseStatus: Recruiting, Estimated PCD: 2043-02-01
Product
Sequential sampling